Corium, LLC, a commercial-stage biopharmaceutical company developing novel neuroscience therapies, and Lotus Pharmaceutical, a multinational pharmaceutical company, entered into an exclusive collaboration and license agreement for Adlarity (donepezil transdermal system), an innovative Alzheimer’s dementia treatment, in ten markets across Asia. Adlarity is FDA-approved in the U.S. as the first and only once-weekly patch for the treatment of mild, moderate, and severe dementia of Alzheimer’s. T...